CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer. Xiao Y, Mao L, Yang QC, Wang S, et al. Oral Oncol 2023;138:106331.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xiao Y, Mao L, Yang QC, Wang S, et al. CD103 blockade impair anti-CTLA-4 immunotherapy in oral cancer. Oral Oncol 2023;138:106331.
PMID: 36753904